Frank Kerim Reinecke appointed new Partner at High-Tech Gründerfonds

February 6, 2024

Bonn, 6 February 2024 – Frank Kerim Reinecke has been appointed Partner at High-Tech Gründerfonds (HTGF), one of Europe’s leading seed investors, effective 1 January 2024. The former entrepreneur, IT consultant and initiator of a corporate venture capital unit has been working for HTGF’s Digital Tech team in Berlin since 2019.

His investments are focused on the area of B2B software, particularly fintech, blockchain and cyber security. His 12 portfolio companies include blockchain technology provider Venly, cloud security start-up Mitigant and marketing tech company CI HUB. Having founded numerous companies and invested as a business angel for many years, Reinecke will help strengthen the expertise of HTGF’s team of partners. Alongside his portfolio work and his tasks in the Digital Tech team, he will also focus on cooperation with business angels and HTGF’s fund investor support.

After an apprenticeship as a banker, Reinecke studied business administration at the Humboldt University of Berlin. He founded his first start-up before he’d even completed his degree.

In Frank Reinecke, we are welcoming an experienced entrepreneur and experienced angel investor to our team of partners. His perspectives and experiences greatly enhance the competencies and skills of the whole HTGF team.

Dr. Alex von Frankenberg, Managing Director at HTGF

I’m really excited to help shape the path ahead for HTGF. I’m also looking to leverage my experience as a founder, business angel and CVC initiator to make sure HTGF remains the first point of contact for business angels, start-ups and potential fund investors.

Frank Kerim Reinecke, Partner at HTGF

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

Press
13. February 2025

InfectoPharm invests in AudioCure to advance innovative hearing loss therapy

Drug candidate AC102 in the clinical phase Heppenheim/Berlin, 13 February 2025 – There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical phase-1-studies with the innovative drug candidate AC102 have been promising. AudioCure Pharma, a Berlin-based start-up supported by investors, is driving forward research and development. Now, InfectoPharm, a successful medium-sized company, is joining as a new and essential competence
 
Press
6. February 2025

Modular. Data-driven. Connected. Avelios Medical secures €30 million from Sequoia Capital for its next-generation hospital information system

The funding round is one of the largest Series A rounds in digital health in recent months. Avelios Medical offers the HIS of the future: designed around hospital workflows, powered by modular microservices, and based on structured data to enable AI-driven care. Leading hospitals are successfully using Avelios Medical’s software as the modern alternative in the HIS market. Munich, February 6, 2025 – Avelios Medical, provider of a modern hospital information system (HIS), h